Characterization of a new SARS-CoV-2 variant that emerged in Brazil
Masaki Imai(University of Wisconsin–Madison), Tsuguto Fujimoto(National Institute of Infectious Diseases), Michiko Koga(Tokyo University of Science), Samantha Loeber(University of Wisconsin–Madison), Osamu Akasaka(Fujisawa City Hospital), Hiroshi Ueki(Tokyo University of Science), Atsuhiro Yasuhara(Tokyo University of Science), Amie J. Eisfeld(University of Wisconsin–Madison), Shuetsu Fukushi(National Institute of Infectious Diseases), Hideaki Nakajima(Yokohama City University), Tiago J. S. Lopes, Shinya Yamamoto(Tokyo University of Science), Shelby L. O’Connor(University of Wisconsin–Madison), S. Chiba(University of Wisconsin–Madison), Yusuke Miyazato(National Center for Global Health and Medicine), Tetsuya Suzuki(National Institute of Infectious Diseases), David H. O’Connor(University of Wisconsin System), Seiya Yamayoshi(Tokyo University of Science), Kiyoko Iwatsuki‐Horimoto(Tokyo University of Science), Rie Baba(Saiseikai Utsunomiya hospital), John J. Baczenas(University of Wisconsin–Madison), Kensuke Fujita, Kenji Maeda(National Institute of Infectious Diseases), Michiko Ujie(Tokyo University of Science), Ichiro Nakachi(Saiseikai Utsunomiya hospital), Makoto Kuroda(University of Wisconsin–Madison), Moe Okuda(The University of Tokyo), Masato Hatta(University of Wisconsin–Madison), Junichi Ochi(Eiju General Hospital), Maki Kiso(Tokyo University of Science), Kazuma Yagi(Keio University), Peter Halfmann(University of Wisconsin–Madison), Morio Nakamura(Saiseikai Central Hospital), Takayuki Ogura(Saiseikai Utsunomiya hospital), Carmen Gherasim(University of Michigan), Yuri Furusawa(Tokyo University of Science), Eisuke Adachi(Tokyo University of Science), Yuko Sakai‐Tagawa(Tokyo University of Science), Hideaki Kato(Yokohama City University Hospital), Makoto Saito(Tokyo University of Science), Noriko Nakajima(National Institute of Infectious Diseases), David Baker(University of Wisconsin Foundation), Hiroyuki Nagai(University of Tokyo Hospital), Riccardo Valdez(University of Michigan), Kenta Takahashi(National Institute of Infectious Diseases), Mutsumi Ito(Tokyo University of Science), Shin-ichiro Hattori(National Center for Global Health and Medicine), Keiko Mitamura(Eiju General Hospital), Tokiko Watanabe, Tadashi Maemura(University of Wisconsin–Madison)
Cited by 87
Related Papers
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
|Nature|2012|1.5k
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
|The Lancet Oncology|2019|636
Transmission of SARS-CoV-2 in Domestic Cats
|New England Journal of Medicine|2020|527